Healthcare investment firm focused on emerging development stage private and public biotechnology and medical device companies. We specialize in the acquisition and development of therapeutic products through the formation of new companies to develop novel therapeutics for unmet medical needs. We utilize our internal capital, experience and extensive industry network to rapidly and efficiently push products forward in the approval pathway. Our companies partner with academic institutions as well as emerging and established biotechnology companies to assemble assets.

Invested in public and private biotech companies. Responsible for the acquisition of numerous therapeutic candidates and formation of multiple private and public biotech companies in a variety of specialties including neurology, dermatology, oncology, cardiovascular.

Strategic and capital markets consulting to executive management teams of publicly traded biotechnology companies